Templeton, Nancy Smyth
Baylor College of Medicine,
United States
2025 Rank: 144534
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 453 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 144534 | 153903 |
| Total Cites | 2601 | 2972 |
| H-index | 27 | 29 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 338 | 350 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1316 | 1380 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 1617 | 1702 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2388 | 2567 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.16 |
| Self-Citation Percentage |
12.48%
|
|
Templeton, Nancy Smyth
Baylor College of Medicine,
United States
2024 Rank: 137600
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 414 out of 62673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 137600 | 144817 |
| Total Cites | 2538 | 2902 |
| H-index | 26 | 29 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 327 | 339 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1291 | 1353 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 1588 | 1671 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2327 | 2502 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.16 |
| Self-Citation Percentage |
12.54%
|
|
Templeton, Nancy Smyth
Gradalis, Inc,
United States
2023 Rank: 130368
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 398 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130368 | 137338 |
| Total Cites | 2490 | 2847 |
| H-index | 25 | 28 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 317 | 329 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1271 | 1331 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 1568 | 1648 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2286 | 2460 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.16 |
| Self-Citation Percentage |
12.54%
|
|
Templeton, Nancy Smyth
Gradalis, Inc,
United States
2022 Rank: 124432
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 375 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124432 | 132613 |
| Total Cites | 2409 | 2759 |
| H-index | 25 | 28 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 307 | 318 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1239 | 1297 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 1534 | 1611 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2208 | 2381 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.16 |
| Self-Citation Percentage |
12.69%
|
|
Templeton, Nancy Smyth
Gradalis, Inc,
United States
2021 Rank: 119104
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 347 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119104 | 126907 |
| Total Cites | 2364 | 2710 |
| H-index | 25 | 28 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 297 | 308 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1217 | 1273 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 1510 | 1585 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2168 | 2337 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.16 |
| Self-Citation Percentage |
12.77%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.